An alternative cyclin-D1 splice site is not linked to inflammatory bowel disease-associated neoplasia

International Journal of Biological Markers

Volumn 25, Issue 1, 2010, Pages 27-31

  Kanaan, Ziad ^a   Eichenberger, M Robert ^a   Young, Michael ^a   Colliver, Daniel ^a   Crawford, Nigel ^a   Cobbs, Gary A ^b   Hein, David W ^a   Galandiuk, Susan ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Crohn's disease; Cyclin D1; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

ADENOSINE; CYCLIN D1; DNA; GUANOSINE;

ALTERNATIVE RNA SPLICING; ARTICLE; CASE CONTROL STUDY; COLITIS; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; DNA EXTRACTION; EXON; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 77951001903     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460081002500104     Document Type: Article

References (20)

1. Greenstein AJ. Cancer in inflammatory bowel disease. Mt Sinai J Med 2000; 67: 227-240
2. Colliver DW, Crawford NP, Eichenberger MR, et al. Molecular profiling of ulcerative colitis-associated neoplastic progression. Exp Mol Pathol 2006; 80: 1-10.
3. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995; 11: 1005-1011
4. Online Mendelian Inheritance in Man, OMIM™. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), April 9, 2009. http://www.ncbi.nlm.nih.gov/omim/
5. Wang L, Habuchi T, Takahashi T, et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 2002; 23: 257-264 (Pubitemid 34224000)
6. Wang L, Habuchi T, Mitsumori K, et al. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism. Int J Cancer 2003; 103: 116-120 (Pubitemid 35424214)
7. Kong S, Amos CI, Luthra R, Lynch PM, Levin B, Frazier ML. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res 2000; 60: 249-252 (Pubitemid 30070744)
8. Kong S, Wei Q, Amos CI, et al. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst 2001; 93: 1106-1108 (Pubitemid 32717544)
9. Le Marchand L, Seifried A, Lum-Jones A, Donlon T, Wilkens LR. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA 2003; 290: 2843-2848 (Pubitemid 37509493)
10. Lee KM, Park SK, Kim SU, et al. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer. Cancer Lett 2003; 196: 179-186
11. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100: 9440-9445
12. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006; 25: 1620-1628
13. Bala S, Peltomäki P. Cyclin D1 as a genetic modifier in hereditary nonpolyposis colorectal cancer. Cancer Res 2001; 61: 6042-6045 (Pubitemid 32762536)
14. Grieu F, Malaney S, Ward R, Joseph D, Iacopetta B. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res 2003; 23: 4257-4259 (Pubitemid 37474930)
15. Hong Y, Eu KW, Seow-Choen F, Fook-Chong S, Cheah PY. GG genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Eur J Cancer 2005; 41: 1037-1044 (Pubitemid 40602856)
16. Porter TR, Richards FM, Houlston RS, et al. Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene 2002; 21: 1928-1933.
17. McKay JA, Douglas JJ, Ross VG, et al. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int J Cancer 2000; 88: 77-81.
18. Lewis RC, Bostick RM, Xie D, et al. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 2003; 63: 8549-8553
19. Wong NA, Mayer NJ, Anderson CE, et al. Cyclin D1 and p21 in ulcerative colitis-related inflammation and epithelial neoplasia: a study of aberrant expression and underlying mechanisms. Hum Pathol 2003; 34: 580-588
20. Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP, Yu MC. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis 2006; 27: 2475-2482 (Pubitemid 44884106)